fis1 Antibody

What is Fis1 protein and what is its functional significance?

Fis1 (mitochondrial fission 1 protein) is a crucial component of the mitochondrial dynamics machinery, specifically involved in mitochondrial fission processes. This protein localizes to the outer mitochondrial membrane where it plays an essential role in maintaining cellular health and energy production through regulating mitochondrial division . Fis1 contains distinct structural domains that contribute to its function: a C-terminal domain necessary for its localization to the mitochondrial membrane and an N-terminal domain that is essential for the fission activity . The protein's importance extends beyond basic cellular functions, as it operates at the intersection of cell survival and programmed cell death pathways.

Functionally, Fis1 acts as a receptor-like protein that works in concert with dynamin-related protein 1 (Drp1) to facilitate mitochondrial division . This interaction is evolutionarily conserved and represents a fundamental mechanism for maintaining appropriate mitochondrial network morphology. When mitochondrial fission becomes dysregulated due to Fis1 dysfunction, the resulting imbalance between fission and fusion processes can trigger serious pathological states, including neurodegenerative diseases and cancer . Furthermore, excessive mitochondrial network fragmentation mediated by Fis1 can initiate cytochrome c release, highlighting Fis1's dual role in both promoting cell survival under normal conditions and regulating programmed cell death when necessary .

Which experimental techniques are compatible with Fis1 antibody?

Fis1 antibodies are versatile research tools validated for multiple experimental techniques essential for mitochondrial research. Both the B-5 and C-10 variants of Fis1 antibody have been validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA) . Additionally, the B-5 variant has been specifically validated for immunohistochemistry applications, expanding its utility for tissue analysis . This methodological versatility enables researchers to investigate Fis1 from multiple angles within the same research project.

For enhanced experimental flexibility, Fis1 antibodies are available in both non-conjugated forms and various conjugated formats to suit specific research requirements. These conjugation options include agarose (for pull-down applications), horseradish peroxidase (HRP for enhanced chemiluminescent detection), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for flow cytometry and fluorescence microscopy . Additionally, multiple Alexa Fluor® conjugates are available for advanced fluorescence imaging applications with different excitation/emission requirements . This range of detection modalities allows researchers to design complex experiments with multiple labeling strategies, facilitating colocalization studies with other mitochondrial proteins or investigating Fis1 dynamics in relation to other cellular structures.

How is the specificity of Fis1 antibody determined across different species?

Fis1 antibodies demonstrate cross-species reactivity that makes them valuable for comparative studies across mammalian models. Both the B-5 and C-10 variants of Fis1 antibody can detect Fis1 protein from mouse, rat, and human origin, indicating significant conservation of immunogenic epitopes across these species . This cross-reactivity is particularly beneficial for researchers working with multiple model systems or translating findings between animal models and human samples. The consistent performance across species facilitates more reliable comparative studies of mitochondrial dynamics in different experimental contexts.

The specificity of the B-5 variant is precisely defined at the molecular level, as it was raised against amino acids 1-152, representing the full-length Fis1 protein of human origin . This comprehensive epitope coverage ensures recognition of the complete protein structure rather than just a small peptide region, potentially enhancing the antibody's ability to detect native conformations of the protein. For validation of antibody specificity, researchers should perform appropriate controls including western blotting to confirm a single band at the expected molecular weight (approximately 17 kDa for Fis1), positive and negative control samples (such as Fis1 overexpression and knockdown), and peptide competition assays to confirm epitope specificity, especially when applying these antibodies to less commonly tested species or experimental conditions.

How can Fis1 antibody be used to investigate the Fis1-Drp1 interaction mechanism?

Investigating the Fis1-Drp1 interaction requires multiple complementary approaches, with Fis1 antibody serving as a critical tool for several of these methods. Immunoprecipitation (IP) using Fis1 antibody can directly capture Fis1-Drp1 complexes from cellular lysates, enabling researchers to study the interaction under various physiological and pathological conditions . This technique can be particularly powerful when combined with subsequent western blotting analysis to quantify the relative abundance of interacting proteins or mass spectrometry to identify additional binding partners within the complex. For optimal results, researchers should optimize lysis conditions to preserve membrane protein interactions, considering detergents that maintain native protein conformations.

Microscopy-based approaches represent another important methodology for studying this interaction. Immunofluorescence with Fis1 antibody combined with Drp1 labeling can reveal colocalization patterns at potential fission sites on mitochondria . Advanced techniques such as proximity ligation assay (PLA) or Förster resonance energy transfer (FRET) using conjugated Fis1 antibodies can provide evidence of direct protein-protein interactions at the nanometer scale. Recent structural studies have revealed that human Fis1 directly interacts with Drp1 through two key structural features: its N-terminal arm and a conserved surface . Researchers can leverage this knowledge to design experiments targeting specific regions of the interaction, such as using Fis1 constructs with mutations in these regions (e.g., N-terminal arm deletions or substitutions at conserved residues) followed by immunoprecipitation with Fis1 antibody to assess the impact on Drp1 binding.

What insights have mutagenesis studies revealed about Fis1 function in mitochondrial dynamics?

Alanine scanning mutagenesis of the Fis1 N-terminal arm has uncovered critical residues that dramatically influence mitochondrial morphology, demonstrating Fis1's profound regulatory effect on mitochondrial dynamics. Specific mutations in this region produce contrasting phenotypes ranging from highly elongated mitochondria (N6A mutant) to severely fragmented mitochondrial networks (E7A mutant) . These opposing outcomes from substitutions at adjacent amino acid positions highlight the precise molecular tuning capabilities of the Fis1 protein. Additionally, mutagenesis of a conserved residue, Y76, revealed another critical site for Fis1 function, as substitution to alanine (Y76A) resulted in highly fragmented mitochondria, while replacement with phenylalanine (Y76F) did not produce this effect .

These findings suggest a complex regulatory mechanism involving intramolecular interactions between the Fis1 arm and a conserved surface on the protein that ultimately influences Drp1-mediated fission . For researchers investigating Fis1 function, these mutants provide valuable tools to manipulate mitochondrial morphology in a controlled manner. When using Fis1 antibody to study these mutants, researchers should first confirm that the mutations do not affect antibody recognition, particularly if the antibody's epitope includes the modified regions. Experimental approaches might include transfecting cells with mutant Fis1 constructs followed by immunofluorescence with mitochondrial markers and Fis1 antibody to visualize morphological changes, or immunoprecipitation to assess how these mutations affect interactions with Drp1 and other binding partners.

How does Fis1 contribute to pathological conditions and what research approaches can investigate this?

Disruption of the delicate balance between mitochondrial fission and fusion processes due to Fis1 dysfunction has been implicated in various pathologies, making it an important research target for disease mechanisms. Abnormal Fis1 activity is associated with neurodegenerative diseases and cancer, highlighting its significance in cellular health and disease progression . Researchers can investigate these connections using Fis1 antibody in conjunction with tissue samples from disease models or patients. Immunohistochemistry with Fis1 antibody can reveal altered expression patterns in affected tissues, while western blotting can quantify expression level changes.

Mitochondrial network fragmentation mediated by Fis1 can trigger cytochrome c release, initiating apoptotic pathways and revealing Fis1's dual role in both cellular survival and programmed cell death . This mechanism can be studied using Fis1 antibody in conjunction with cytochrome c antibodies and apoptotic markers to track the sequential events in the cell death cascade. For neurodegenerative disease research, dual labeling with Fis1 antibody and markers of protein aggregation (such as α-synuclein for Parkinson's disease or amyloid-β for Alzheimer's disease) can reveal spatial relationships between mitochondrial dynamics and pathological protein accumulation. Cancer research applications might include comparing Fis1 expression and mitochondrial morphology between normal and malignant tissues, or investigating how targeting Fis1-mediated fission affects cancer cell survival and metabolism.

What are the optimal conditions for using Fis1 antibody in Western blotting?

Optimizing Western blotting protocols for Fis1 detection requires careful consideration of several experimental parameters due to the protein's relatively small size and membrane localization. Standard SDS-PAGE with 12-15% acrylamide gels is recommended for optimal resolution of Fis1, which has a molecular weight of approximately 17 kDa . For membrane transfer, PVDF membranes may provide better retention of this small protein compared to nitrocellulose. Blocking conditions should be optimized empirically, but 5% non-fat dry milk in TBST typically provides sufficient blocking while maintaining antibody specificity. For primary antibody incubation, starting dilutions of 1:200 to 1:1000 are recommended, with overnight incubation at 4°C to maximize specific binding.

Sample preparation is particularly critical for mitochondrial membrane proteins like Fis1. Complete lysis buffers containing both ionic and non-ionic detergents (such as RIPA buffer) are generally effective at extracting Fis1 from the outer mitochondrial membrane . Importantly, researchers should include protease inhibitors in all buffers to prevent degradation, and samples should be kept cold throughout processing. For quantitative comparisons, normalization to appropriate loading controls is essential—either total protein normalization methods or mitochondrial markers such as TOMM20 or VDAC for mitochondrial-specific normalization. When evaluating Fis1 expression changes under experimental conditions, researchers should consider including both positive controls (such as cells with known high Fis1 expression) and negative controls (such as Fis1 knockdown samples) to validate antibody specificity and establish the dynamic range of detection.

How can immunofluorescence with Fis1 antibody be optimized for mitochondrial morphology studies?

Successful visualization of mitochondrial morphology using Fis1 antibody requires attention to both sample preparation and imaging parameters. For optimal preservation of mitochondrial structures, researchers should use mild fixation protocols, such as 4% paraformaldehyde for 10-15 minutes at room temperature, as harsher fixatives may distort mitochondrial networks . Permeabilization should be gentle, with 0.1-0.2% Triton X-100 or 0.1% saponin being suitable options that allow antibody access while preserving mitochondrial structure. When using Fis1 antibody variants with fluorescent conjugates (such as FITC, PE, or Alexa Fluor® conjugates), researchers should consider spectral compatibility with other fluorophores for co-labeling experiments .

What considerations are important for using Fis1 antibody in immunoprecipitation studies?

Immunoprecipitation with Fis1 antibody requires special considerations due to Fis1's membrane localization and its involvement in protein complexes essential for mitochondrial fission. Both B-5 and C-10 variants of Fis1 antibody have been validated for immunoprecipitation applications, providing researchers with options depending on the specific experimental context . For enhanced convenience, agarose-conjugated Fis1 antibody (e.g., Fis1 Antibody (C-10) AC) eliminates the need for secondary antibody or protein A/G beads, potentially improving consistency across experiments . When designing immunoprecipitation protocols, researchers should consider the native binding partners of Fis1, particularly its interaction with Drp1 and mitochondrial fission factor (Mff), which may be co-precipitated under native conditions .

Cell lysis conditions are critical for successful Fis1 immunoprecipitation from mitochondrial membranes. Non-denaturing lysis buffers containing mild detergents such as digitonin (0.5-1%), CHAPS (0.5-1%), or NP-40 (0.5-1%) are often effective for solubilizing membrane proteins while preserving protein-protein interactions . The buffer composition should be optimized based on the specific research question—whether the goal is to preserve Fis1's interactions with binding partners or to isolate Fis1 alone. Pre-clearing lysates with control IgG matching the host species and isotype of the Fis1 antibody (mouse IgG2a for B-5 or mouse IgG1 for C-10) can reduce non-specific binding . For investigating the evolutionarily conserved interaction between Fis1 and Drp1, researchers might consider crosslinking approaches prior to lysis, as this interaction appears to involve complex regulatory mechanisms mediated by the N-terminal arm of Fis1 . Following immunoprecipitation, analysis of the precipitated complexes can provide insights into how mutations in Fis1 (such as the N6A or E7A substitutions) affect its interaction network and consequently influence mitochondrial morphology .

What biochemical methods have revealed the mechanisms of Fis1-Drp1 interaction?

Recent biochemical investigations have provided significant insights into the direct interaction between human Fis1 and Drp1, clarifying evolutionarily conserved mechanisms. Nuclear magnetic resonance (NMR) spectroscopy has been instrumental in characterizing the intramolecular interactions within Fis1, revealing that the N-terminal arm of Fis1 interacts with a conserved surface on the protein itself . This was demonstrated through heteronuclear single quantum coherence (HSQC) NMR experiments using 15N-labeled armless Fis1 constructs (Fis1ΔN) titrated with peptides corresponding to the N-terminal arm sequence, which showed specific chemical shift perturbations indicative of binding . These studies revealed that the arm may regulate Fis1's interaction with Drp1 through an intramolecular switching mechanism.

Multiple complementary techniques have confirmed and characterized the direct Fis1-Drp1 interaction. Differential scanning fluorimetry showed that Fis1ΔN affects the thermal stability of Drp1, particularly its second transition corresponding to the stalk domain, providing evidence of specific binding . Microscale thermophoresis (MST) experiments with fluorescently labeled proteins yielded quantitative binding affinity measurements, with an apparent Kd of 12-15 μM for the Fis1ΔN-Drp1 interaction . Additionally, NMR titration experiments with 15N-Fis1ΔN and increasing Drp1 concentrations showed progressive signal intensity decreases consistent with complex formation, yielding apparent Kd values ranging from 26 to 68 μM . Importantly, control experiments with bovine serum albumin confirmed the specificity of this interaction . For researchers planning to investigate this interaction, these techniques provide a methodological framework that can be adapted to study how specific mutations or conditions affect binding parameters.

How does Fis1 influence Drp1 assembly and function in mitochondrial fission?

The influence of Fis1 on Drp1 assembly represents a key regulatory mechanism in mitochondrial fission that researchers can investigate using specialized biochemical approaches. Microscale thermophoresis assays measuring Drp1 self-assembly in the presence of increasing Fis1ΔN concentrations have revealed that Fis1 appears to weaken Drp1's propensity to self-assemble, with nearly a 10-fold decrease in apparent Kd for Drp1 assembly at high Fis1ΔN concentrations . This inhibitory effect on assembly occurs despite Fis1ΔN having no significant impact on Drp1's GTP hydrolysis activity, as demonstrated through phosphate release assays . These findings suggest a regulatory mechanism where Fis1 may modulate Drp1 function by affecting its assembly state rather than its enzymatic activity.

For researchers investigating this complex interplay, a multi-method approach is recommended. In vitro assays with purified proteins can provide mechanistic insights, while cellular studies using Fis1 antibody can connect these mechanisms to physiological outcomes. Immunofluorescence studies with Fis1 and Drp1 antibodies can visualize the recruitment and assembly of Drp1 at mitochondrial fission sites under various conditions . Combined with the expression of Fis1 mutants (such as N6A, E7A, or Y76A), these approaches can reveal how specific structural features of Fis1 influence Drp1 assembly and function in cells . Time-resolved studies tracking the dynamics of these processes can further illuminate the sequence of events in mitochondrial fission. Additionally, researchers might consider investigating how post-translational modifications of either Fis1 or Drp1 affect their interaction and the subsequent fission process, potentially uncovering additional regulatory layers.

What is the significance of the N-terminal arm of Fis1 in regulating protein interactions?

The N-terminal arm of Fis1 plays a crucial regulatory role in protein interactions and mitochondrial morphology, making it a key target for structure-function studies. NMR experiments have demonstrated that the arm (residues 1-8, sequence EAVLNEL) can bind to an armless Fis1 construct (Fis1ΔN), suggesting an intramolecular interaction that may regulate Fis1's ability to bind other proteins . This auto-regulatory mechanism appears evolutionarily significant, as removal of the arm reveals a latent interaction with Drp1 in vitro, indicating that the arm might normally occlude Drp1 binding in a manner similar to the yeast system . For researchers investigating this regulatory mechanism, experiments comparing full-length Fis1 with armless constructs can provide insights into how this domain controls protein function.

The dramatic phenotypic effects of single amino acid substitutions in the N-terminal arm underscore its importance in regulating mitochondrial morphology. Alanine scanning mutagenesis has identified both loss-of-function (N6A, causing elongated mitochondria) and gain-of-function (E7A, causing fragmented mitochondria) mutations within this short sequence . These opposing phenotypes from adjacent residues highlight the fine-tuning capabilities of this regulatory element. Researchers can leverage these mutations as tools to manipulate mitochondrial morphology in experimental systems. For investigating the structural basis of these effects, a combination of in vitro binding assays with mutant proteins and cellular studies using Fis1 antibody to track localization and interaction changes can be informative. Additionally, computational modeling approaches may help predict how these mutations alter the conformational dynamics of the arm and its interaction with the core Fis1 structure, providing hypotheses that can be tested experimentally with Fis1 antibody and other biochemical methods.

How should researchers address inconsistent results when using Fis1 antibody?

Inconsistent results with Fis1 antibody can stem from multiple sources, requiring systematic troubleshooting to identify and resolve underlying issues. Sample preparation variability often contributes to inconsistency, particularly since Fis1 is a membrane-bound protein requiring appropriate extraction conditions . Researchers should standardize their lysis protocols, ensuring complete solubilization of mitochondrial membrane proteins while preventing protein degradation through the consistent use of protease inhibitors. Additionally, the fixation and permeabilization conditions for immunofluorescence applications can significantly impact antibody accessibility to mitochondrial membranes, necessitating optimization and standardization of these parameters across experiments .

Technical variations in antibody handling can also contribute to inconsistent results. Researchers should maintain consistent antibody storage conditions (-20°C for most antibody preparations) and avoid repeated freeze-thaw cycles that can compromise antibody integrity . For quantitative applications such as western blotting, standardizing antibody dilutions, incubation times, and detection methods is essential for obtaining comparable results across experiments. When troubleshooting specific applications, researchers should consider the distinct requirements of each technique—for instance, western blotting may require denaturing conditions that expose epitopes differently than native immunoprecipitation or immunofluorescence applications. Finally, cellular context can influence Fis1 detection, as its expression and localization may vary with cell type, confluency, metabolic state, and stress conditions. Including appropriate positive controls (such as cells with validated Fis1 expression) and negative controls (such as Fis1 knockdown cells or peptide competition assays) in each experiment can help distinguish true Fis1 signal from background or non-specific binding, aiding in consistent interpretation of results.

How can researchers distinguish between direct and indirect effects on mitochondrial morphology when studying Fis1?

Distinguishing direct Fis1-mediated effects from indirect consequences on mitochondrial morphology requires careful experimental design and control strategies. Time-course experiments can help establish the sequence of events following Fis1 manipulation, providing insights into which morphological changes occur first and might therefore be direct consequences of Fis1 activity . Acute interventions, such as rapid protein inactivation techniques (e.g., auxin-inducible degron systems applied to Fis1), can help separate immediate effects from secondary adaptations that develop over longer timeframes. Additionally, dose-response studies with Fis1 overexpression or knockdown can establish whether morphological changes correlate proportionally with Fis1 levels, which would support a direct relationship.

Complementary approaches can provide further evidence for direct versus indirect effects. Rescue experiments reintroducing wild-type or mutant Fis1 (such as the N6A or E7A variants) into Fis1-depleted cells can demonstrate which phenotypes are directly rescuable by Fis1 function . Structure-function studies correlating specific Fis1 domains or mutations with particular morphological outcomes can establish mechanistic links—for instance, the finding that Y76A mutation causes mitochondrial fragmentation similar to E7A suggests a common mechanism involving the interaction between Fis1's arm and its conserved surface . For a comprehensive understanding, researchers should also investigate other mitochondrial dynamics proteins (such as Drp1, Mff, and fusion machinery components) to assess whether Fis1 manipulations affect their localization or activity, potentially causing indirect effects. Combining Fis1 antibody labeling with markers for these other proteins in immunofluorescence or co-immunoprecipitation experiments can reveal such relationships. Finally, considering cellular context is crucial, as energy status, cell cycle phase, and stress conditions can all influence mitochondrial morphology independently of direct Fis1 effects, necessitating appropriate controls for these variables in experimental design.

What controls are essential when making quantitative comparisons of Fis1 expression levels?

Rigorous control strategies are essential for reliable quantitative comparisons of Fis1 expression across experimental conditions. For western blotting applications, researchers should implement loading controls appropriate to the experimental context—housekeeping proteins such as β-actin or GAPDH for whole-cell lysates, or mitochondrial markers such as TOMM20 or VDAC for studies focused on mitochondrial protein changes . Importantly, the linear dynamic range of detection should be established for both Fis1 and the chosen loading control to ensure that measurements fall within the quantifiable range. Including standard curves with known quantities of recombinant Fis1 protein can provide absolute quantification references, while serial dilutions of experimental samples can confirm linearity of detection.

Technical controls that account for experimental variables are equally important. For antibody specificity validation, peptide competition assays (where the antibody is pre-incubated with excess Fis1 peptide) can confirm that the observed signal is specific to Fis1 . Biological controls should include positive controls (cells known to express Fis1) and negative controls (Fis1 knockdown or knockout cells) to establish the dynamic range and specificity of detection. When comparing Fis1 expression across different cellular contexts, researchers should consider potential confounding factors such as cell cycle phase, confluency, and metabolic state, which may independently affect mitochondrial protein expression. Standardizing these conditions or explicitly controlling for them in the analysis can improve the reliability of comparisons. Finally, statistical considerations are crucial for meaningful quantitative comparisons—researchers should conduct sufficient biological replicates (minimum n=3, preferably more) and apply appropriate statistical tests based on data distribution characteristics. When reporting results, both the magnitude of changes and their statistical significance should be clearly presented, along with transparent descriptions of normalization methods and analysis parameters to facilitate reproducibility.